AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
0.570
+0.011 (1.93%)
At close: Nov 20, 2024, 4:00 PM
0.569
-0.001 (-0.19%)
After-hours: Nov 20, 2024, 4:04 PM EST

AlloVir Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
65.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019165.00K-970.00K-85.46%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CytomX Therapeutics 126.62M
Atara Biotherapeutics 100.44M
Metagenomi 55.08M
bluebird bio 53.12M
Cryo-Cell International 31.84M
Cue Biopharma 9.53M
InspireMD 6.82M
Pheton Holdings 572.29K
Revenue Rankings